WAVE Life Sciences Ltd (NAS:WVE)
$ 5.74 0.22 (3.99%) Market Cap: 716.00 Mil Enterprise Value: 590.91 Mil PE Ratio: 0 PB Ratio: 0 GF Score: 63/100

WAVE Life Sciences Ltd Genetic Medicines and Cell Therapy Manufacturing Summit Transcript

Apr 26, 2022 / 06:30PM GMT
Release Date Price: $1.83 (-9.41%)
Keay Thomas Nakae
Chardan Capital Markets, LLC, Research Division - Senior Research Analyst of Therapeutics, Devices and Diagnostics

It's my pleasure to introduce our next guest from Wave Life Sciences, President and Chief Executive Officer, Dr. Paul Bolno; and Senior Vice President, CMC, Dr. Sri Vaddeboina. (Operator Instructions) Paul and Sri, thank you both so much for joining us today.

I think to start, Paul, could you please provide a couple of minutes of introductory comments about Wave for investors new to the story?

Paul B. Bolno
Wave Life Sciences Ltd. - President, CEO & Director

Yes. No. Thank you, Keay, and we appreciate Chardan for hosting us on today's summit. And it's a great topic talking about manufacturing. When we introduced the company and for the subsequent part of the discussion, just a reminder that we can make a forward-looking statement during the discussion. So I please refer everybody to our SEC filings for an update.

But Keay, as you said, beyond manufacturing and stepping back, since our foundation and we've

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot